BRCA1 and neoplasm: For example, secondary mutations of BRCA1 or BRCA2 (essential factors in the HR pathway) caused by chemotherapy using cisplatin or poly(ADP-ribose) polymerase inhibitor in BRCA1/2-mutated cancers restore the wild-type reading frame and, therefore, the tumor acquires resistance to these drugs [6-8].